2 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study of HRS-6208 in Combination With HRS-8080, or Fulvestrant, or Letrozole, With or Without HRS-6209 in Patients With Advanced Unresectable or Metastatic Breast CancerAdvanced Unresectable or Metastatic Breast Cancer of AdultsRecruitingPhase 1 / Phase 22026-04-03NCT07389733
Chinese AntiphosPholipid Syndrome cohorT cOllaborative NEtworksantiphospholipid syndrome, autoimmune disease, immune system disorderRecruitingNot stated2024-07-30NCT05230017